Document Detail

Beckwith-wiedemann syndrome: potassium ascorbate with ribose therapy in a syndrome with high neoplastic risk.
MedLine Citation:
PMID:  22110229     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: Beckwith-Wiedemann Syndrome (BWS) is a genomic imprinting disorder characterized by overgrowth and increased risk of malignancy. We studied the oxidative stress (OS) pattern of our patients with BWS and administered, for the first time, potassium ascorbate with ribose (PAR) once a day as long-term therapy in order to correct the effects induced by free radicals.
PATIENTS AND METHODS: We describe the clinical features of three patients examined every three months in our clinic. OS was ascertained by measuring a panel of OS biomarkers: non-protein-binding iron, total hydroperoxides, advanced oxidation protein products, isoprostanes, carbonyl groups and thiols. After the presence of OS was established, treatment with PAR was started at the dosage of 300 mg of Potassium Bicarbonate and 150 mg of Ascorbic Acid in aqueous solution and changes occurring in OS biomarkers were followed dosing every three months.
RESULTS: Our patients showed higher levels of OS biomarkers than controls at the time of diagnosis. There was a reduction in OS biomarker values for all three patients with treatment. No primary or secondary neoplastic disease was observed in 9 months of follow-up.
CONCLUSION: This is the first report showing OS occurring in BWS. No drug until this report has been published showing efficacy against OS in any cancer. Given the limited number of patients, care must be taken to mitigate enthusiasm. We are collecting data for a large number of BWS patients to confirm these preliminary results.
Cecilia Anichini; Caterina Lo Rizzo; Mariangela Longini; Guido Paoli; Rosanna Maria DI Bartolo; Fabrizio Proietti; Giuseppe Buonocore
Related Documents :
21937369 - Ultrasonography for leukocytosis or elevated c-reactive protein.
19283329 - High frequency of lipoprotein risk levels for cardiovascular disease in takayasu arteri...
21893129 - Muscle wasting is associated with mortality in patients with cirrhosis.
22467099 - Elevation of ca 125 and ca 19-9 in patients with end-stage liver disease.
21903739 - Between-patient and within-patient (site-to-site) variability in estrogen receptor bind...
22907559 - Catalase and lipid peroxidation values in serum of tunisian patients with pemphigus vul...
8794729 - Vertical duane's retraction syndrome.
532539 - Cameco anaesthetic ventilator with a modified mapleson d circuit.
15042689 - Strongyloidiasis in patients at a comprehensive cancer center in the united states.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Anticancer research     Volume:  31     ISSN:  1791-7530     ISO Abbreviation:  Anticancer Res.     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  3973-6     Citation Subset:  IM    
Department of Pediatrics, Obstetrics and Reproductive Medicine, University of Siena, Viale Mario Bracci 36, 53100 Siena, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Arterial Blood Pressure, Serum Calcium and PTH in Elderly Men with Parathyroid Tumors and Primary Hy...
Next Document:  Characterization of dysplastic nodules, early hepatocellular carcinoma and progressed hepatocellular...